The role of matrix metalloproteinases in the epithelial‐mesenchymal transition of hepatocellular carcinoma

C Scheau, IA Badarau, R Costache… - Analytical cellular …, 2019 - Wiley Online Library
The epithelial‐mesenchymal transition (EMT) is a transformation process mandatory for the
local and distant progression of many malignant tumors, including hepatocellular carcinoma …

The protease ADAM17 at the crossroads of disease: Revisiting its significance in inflammation, cancer, and beyond

MI Saad, BJ Jenkins - The FEBS Journal, 2024 - Wiley Online Library
The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the
pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of …

A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer

DJ Cheon, Y Tong, MS Sim, J Dering, D Berel… - Clinical cancer …, 2014 - AACR
Purpose: To elucidate molecular pathways contributing to metastatic cancer progression
and poor clinical outcome in serous ovarian cancer. Experimental Design: Poor survival …

Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury

C Schrimpf, C Xin, G Campanholle, SE Gill… - Journal of the …, 2012 - journals.lww.com
Kidney pericytes are progenitors of scar-forming interstitial myofibroblasts that appear after
injury. The function of kidney pericytes as microvascular cells and how these cells detach …

TIMP-3 as a therapeutic target for cancer

CW Su, CW Lin, WE Yang… - Therapeutic advances in …, 2019 - journals.sagepub.com
Tissue inhibitor of metalloproteinase-3 (TIMP-3), a secreted glycoprotein, plays an important
role in carcinogenesis. It can bind to many proteinases to suppress their activity and thus …

Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer

D Peeney, Y Liu, C Lazaroff, S Gurung… - …, 2022 - academic.oup.com
Tissue inhibitors of metalloproteinases (TIMPs) are a conserved family of proteins that were
originally identified as endogenous inhibitors of matrixin and adamalysin endopeptidase …

ADAM17: an emerging therapeutic target for lung cancer

MI Saad, S Rose-John, BJ Jenkins - Cancers, 2019 - mdpi.com
Lung cancer is the leading cause of cancer-related mortality, which histologically is
classified into small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) …

HNSCC: tumour antigens and their targeting by immunotherapy

A von Witzleben, C Wang, S Laban, N Savelyeva… - Cells, 2020 - mdpi.com
Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of
malignant tumours typically caused by alcohol and tobacco consumption, although an …

ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion

LJ Xiao, P Lin, F Lin, X Liu, W Qin… - International …, 2012 - spandidos-publications.com
ADAM17, also known as tumor necrosis factor-α converting enzyme (TACE), is involved in
proteolytic ectodomain shedding of cell surface molecules and cytokines. Although aberrant …

Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device

G Galletti, MS Sung, LT Vahdat, MA Shah… - Lab on a Chip, 2014 - pubs.rsc.org
Circulating tumor cells (CTCs) have emerged as a reliable source of tumor cells, and their
concentration has prognostic implications. CTC capture offers real-time access to cancer …